Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

How will a new “biosimilar” insulin compare to Sanofi’s Lantus?
Can a one-day workshop improve diabetes distress and A1c in adults with type 1 diabetes?
Can a type 2 diabetes drug work for type 1? Will an experimental drug improve blood glucose and body weight?
Can a drug for type 2 diabetes work for those with type 1? How will a new basal insulin compare to Lantus?
Gary Scheiner searches for the happy medium between neglecting your diabetes care and being completely overwhelmed.
By Hannah Deming Lately, the use of basal insulins (such as Lantus and Levemir) in combination with GLP-1 agonists (such as Byetta , Victoza , and Bydureon ) has been...
Novo Nordisk’s once daily GLP-1 agonist Victoza (above) provided slightly better improvements in blood glucose control than Amylin/Eli Lilly/ Alkermes’s once weekly GLP-...